Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples

Arch Dermatol. 2002 Jan;138(1):29-32. doi: 10.1001/archderm.138.1.29.

Abstract

Background: Toxic epidermal necrolysis (TEN) is a rare but severe adverse drug disease, characterized by extensive skin and mucosal detachment with participation of different immunoinflammatory pathways, in particular with early participation of activated CD8+ T lymphocytes.

Objective: To further study the potential role of T lymphocytes in the early phase of keratinocyte necrosis.

Design: Prospective study.

Setting: University hospitals.

Patients: Thirteen patients with clinical and histopathologic criteria of TEN and 6 patients with second-degree burns.

Main outcome measures: Measurement of soluble interleukin (IL) 2 receptor (sIL-2R) and IL-1alpha in serum samples and fluid of recent blisters.

Results: In the blister fluid of patients with TEN, we found significantly higher levels of sIL-2R than in patients with burns, whereas IL-1alpha levels were higher in the blister fluid of burned patients. No significant differences were found in serum samples of patients with TEN and burns, in either sIL-2R or IL-1alpha. In TEN we also found significantly higher levels of sIL-2R in the blister fluid compared with serum samples, pointing to a predominantly local production contrasting with the low concentration of sIL-2R in the blister fluid of burned patients.

Conclusions: Our findings of elevated sIL-2R levels in blister fluid of patients with TEN are probably related to a local down-regulation of an immunologically mediated cytotoxic reaction and further support the involvement of activated T lymphocytes in the early blisters of TEN.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / blood
  • Blister
  • Burns / blood
  • Burns / diagnosis*
  • Female
  • Humans
  • Interleukin-1 / blood*
  • Male
  • Middle Aged
  • Probability
  • Prospective Studies
  • Receptors, Interleukin-2 / blood*
  • Reference Values
  • Sensitivity and Specificity
  • Severity of Illness Index
  • Stevens-Johnson Syndrome / blood
  • Stevens-Johnson Syndrome / diagnosis*

Substances

  • Biomarkers
  • Interleukin-1
  • Receptors, Interleukin-2